{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:12:48Z","timestamp":1779898368652,"version":"3.53.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T00:00:00Z","timestamp":1680912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010606","name":"Nuclear Science and Technology Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010606","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00432-023-04724-z","type":"journal-article","created":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T12:02:46Z","timestamp":1680955366000},"page":"7779-7791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Development of 177Lu-Cetuximab-PAMAM dendrimeric nanosystem: a novel theranostic radioimmunoconjugate"],"prefix":"10.1007","volume":"149","author":[{"given":"Seyed Mohammad","family":"Hosseini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Mohammadnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Yousefnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrouz","family":"Alirezapour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Hossein","family":"Rezayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,8]]},"reference":[{"key":"4724_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.apmt.2018.05.002","volume":"12","author":"F Abedi-Gaballu","year":"2018","unstructured":"Abedi-Gaballu F, Dehghan G, Ghaffari M, Yekta R, Abbaspour-Ravasjani S, Baradaran B, Dolatabadi JEN, Hamblin MR (2018) PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy. Appl Mater Today 12:177\u2013190. https:\/\/doi.org\/10.1016\/j.apmt.2018.05.002","journal-title":"Appl Mater Today"},{"key":"4724_CR2","first-page":"S461","volume":"43","author":"B Alirezapour","year":"2016","unstructured":"Alirezapour B, Hadad Dabaghi H, Ansari Ramandi H, Ghamoushi Ramandi A, Hashemizadeh M, Maadi E, Jalilian A, Rajabifar S, Moradkhani S, Masoumi H, Rahiminejad A (2016a) Radiolabeling and quality control of In-111-CHX-A-DTPA-trastuzumab for radioimmunoscintigraphy. Eur J Nucl Med Mol Imaging 43:S461\u2013S461","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4724_CR3","first-page":"S463","volume":"43","author":"B Alirezapour","year":"2016","unstructured":"Alirezapour B, Hadad Dabaghi H, Ghamoushi Ramandi A, Ansari Ramandi H, Soltani N, Hashemizadeh M, Bolorinovin F, Aslan G, Ashtari P (2016b) Radiolabeling and quality control of Ga-67-DTPA-cetuximab for radioimmunoscintigraphy. Eur J Nucl Med Mol Imaging 43:S463\u2013S463","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4724_CR4","doi-asserted-by":"publisher","first-page":"103811","DOI":"10.1016\/j.bioorg.2020.103811","volume":"99","author":"A Ayati","year":"2020","unstructured":"Ayati A, Moghimi S, Salarinejad S, Safavi M, Pouramiri B, Foroumadi A (2020) A review on progression of epidermal growth factor receptor (EGFR) inhibitors as an efficient approach in cancer targeted therapy. Bioorg Chem 99:103811. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103811","journal-title":"Bioorg Chem"},{"key":"4724_CR5","first-page":"4139","volume":"33","author":"S Ayyappan","year":"2013","unstructured":"Ayyappan S, Prabhakar D, Sharma N (2013) Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer. Anticancer Res 33:4139\u20134155","journal-title":"Anticancer Res"},{"key":"4724_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.imlet.2017.07.015","volume":"190","author":"B Bahrami","year":"2017","unstructured":"Bahrami B, Hojjat-Farsangi M, Mohammadi H, Anvari E, Ghalamfarsa G, Yousefi M, Jadidi-Niaragh F (2017) Nanoparticles and targeted drug delivery in cancer therapy. Immunol Lett 190:64\u201383. https:\/\/doi.org\/10.1016\/j.imlet.2017.07.015","journal-title":"Immunol Lett"},{"key":"4724_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3109\/17435390.2013.765054","volume":"8","author":"A Bertero","year":"2014","unstructured":"Bertero A, Boni A, Gemmi M, Gagliardi M, Bifone A, Bardi G (2014) Surface functionalisation regulates polyamidoamine dendrimer toxicity on blood-brain barrier cells and the modulation of key inflammatory receptors on microglia. Nanotoxicology 8:158\u2013168. https:\/\/doi.org\/10.3109\/17435390.2013.765054","journal-title":"Nanotoxicology"},{"key":"4724_CR8","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray F, Laversanne M, Weiderpass E, Soerjomataram I (2021) The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127:3029\u20133030. https:\/\/doi.org\/10.1002\/cncr.33587","journal-title":"Cancer"},{"key":"4724_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/jlcr.3413","volume":"59","author":"R Chakravarty","year":"2016","unstructured":"Chakravarty R, Chakraborty S, Sarma HD, Nair KVV, Rajeswari A, Das A (2016) 90Y\/177Lu-labelled Cetuximab immunoconjugates: radiochemistry optimization to clinical dose formulation. J Label Compd Radiopharm 59:354\u2013363. https:\/\/doi.org\/10.1002\/jlcr.3413","journal-title":"J Label Compd Radiopharm"},{"key":"4724_CR10","first-page":"1190","volume":"8","author":"Z Chen","year":"2016","unstructured":"Chen Z, Gao S, Wang D, Song D, Feng Y (2016) Colorectal cancer cells are resistant to anti-EGFR monoclonal antibody through adapted autophagy. Am J Transl Res 8:1190\u20131196","journal-title":"Am J Transl Res"},{"key":"4724_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.15764\/STAC.2014.02002","volume":"1","author":"I Cieszykowska","year":"2014","unstructured":"Cieszykowska I, Z\u00f3ltowska M, Mielcarski M (2014) Separation of Ytterbium from 177 Lu\/Yb mixture by electrolytic reduction and amalgamation. SOP Trans Appl Chem 1:6\u201313","journal-title":"SOP Trans Appl Chem"},{"issue":"4","key":"4724_CR12","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.bbagen.2006.12.007","volume":"1770","author":"T Dutta","year":"2007","unstructured":"Dutta T, Jain NK (2007) Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer. Biochim Biophys Acta 1770(4):681\u2013686. https:\/\/doi.org\/10.1016\/j.bbagen.2006.12.007","journal-title":"Biochim Biophys Acta"},{"key":"4724_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.apradiso.2007.08.013","volume":"66","author":"Z Dvorakova","year":"2008","unstructured":"Dvorakova Z, Henkelmann R, Lin X, T\u00fcrler A, Gerstenberg H (2008) Production of 177Lu at the new research reactor FRM-II: irradiation yield of 176Lu(n, gamma)177Lu. Appl Radiat Isot 66:147\u2013151","journal-title":"Appl Radiat Isot"},{"key":"4724_CR14","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1042\/BST0320742","volume":"32","author":"KM Ferguson","year":"2004","unstructured":"Ferguson KM (2004) Active and inactive conformations of the epidermal growth factor receptor. Biochem Soc Trans 32:742\u2013745. https:\/\/doi.org\/10.1042\/BST0320742","journal-title":"Biochem Soc Trans"},{"key":"4724_CR15","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev.biophys.37.032807.125829","volume":"37","author":"KM Ferguson","year":"2008","unstructured":"Ferguson KM (2008) Structure-based view of epidermal growth factor receptor regulation. Annu Rev Biophys 37:353\u2013373. https:\/\/doi.org\/10.1146\/annurev.biophys.37.032807.125829","journal-title":"Annu Rev Biophys"},{"key":"4724_CR16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/s1097-2765(03)00047-9","volume":"11","author":"KM Ferguson","year":"2003","unstructured":"Ferguson KM, Berger MB, Mendrola JM, Cho HS, Leahy DJ, Lemmon MA (2003) EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization. Mol Cell 11:507\u2013517. https:\/\/doi.org\/10.1016\/s1097-2765(03)00047-9","journal-title":"Mol Cell"},{"key":"4724_CR17","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.3390\/molecules23092238","volume":"23","author":"M Florendo","year":"2018","unstructured":"Florendo M, Figacz A, Srinageshwar B, Sharma A, Swanson D, Dunbar GL, Rossignol J (2018) Use of polyamidoamine dendrimers in brain diseases. Molecules 23:2238. https:\/\/doi.org\/10.3390\/molecules23092238","journal-title":"Molecules"},{"key":"4724_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.procbio.2021.09.006","volume":"111","author":"P Fotouhi","year":"2021","unstructured":"Fotouhi P, Sohrabi S, Nosrati N, ZamanVaziri A, Khaleghi S, Narmani A, Jafari H, Mohammadnejad J (2021) Surface modified and rituximab functionalized PAMAM G4 nanoparticle for targeted imatinib delivery to leukemia cells: In vitro studies. Process Biochem 111:221\u2013229","journal-title":"Process Biochem"},{"key":"4724_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/0470845821","volume-title":"Dendrimers and other dendritic polymers","author":"JM Frechet","year":"2001","unstructured":"Frechet JM, Tomalia DA (2001) Dendrimers and other dendritic polymers. Wiley, New York"},{"key":"4724_CR20","volume-title":"Design, synthesis and application of novel disulfide-intercalation agents for the site-selective modification of peptides and proteins","author":"C Freidel","year":"2017","unstructured":"Freidel C (2017) Design, synthesis and application of novel disulfide-intercalation agents for the site-selective modification of peptides and proteins. Johannes Gutenberg-Universit\u00e4t Mainz, Mainz"},{"key":"4724_CR21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fonc.2019.00849","volume":"9","author":"J Garc\u00eda-Foncillas","year":"2019","unstructured":"Garc\u00eda-Foncillas J, Sunakawa Y, Aderka D, Wainberg Z, Ronga P, Witzler P, Stintzing S (2019) Distinguishing features of cetuximab and panitumumab in colorectal cancer and other solid tumors. Front Oncol 9:849. https:\/\/doi.org\/10.3389\/fonc.2019.00849","journal-title":"Front Oncol"},{"issue":"7","key":"4724_CR22","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.nano.2013.04.004","volume":"9","author":"HC G\u00e9rard","year":"2013","unstructured":"G\u00e9rard HC, Mishra MK, Mao G, Wang S, Hali M, Whittum-Hudson JA, Kannan RM, Hudson AP (2013) Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine 9(7):996\u20131008. https:\/\/doi.org\/10.1016\/j.nano.2013.04.004","journal-title":"Nanomedicine"},{"key":"4724_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.surfrep.2017.02.001","volume":"72","author":"H Heinz","year":"2017","unstructured":"Heinz H, Pramanik C, Heinz O, Ding Y, Mishra RK, Marchon D, Flatt RJ, Estrela-Lopis I, Llop J, Moya S, Ziolo RF (2017) Nanoparticle decoration with surfactants: molecular interactions, assembly, and applications. Surf Sci Rep 72:1\u201358","journal-title":"Surf Sci Rep"},{"key":"4724_CR24","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.7150\/jca.44234","volume":"11","author":"M Huo","year":"2020","unstructured":"Huo M, Zhao Y, Liu X, Gao Y, Zhang D, Chang M, Liu M, Xu N, Zhu H (2020) EGFR targeting enhances the efficiency of chemotherapy through inhibiting IRE1\u03b1-XBP1s pathway in colorectal cancer cells. J Cancer 11:4464\u20134473. https:\/\/doi.org\/10.7150\/jca.44234","journal-title":"J Cancer"},{"key":"4724_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/cyto.a.22110","volume":"81","author":"M Ingargiola","year":"2012","unstructured":"Ingargiola M, Dittfeld C, Runge R, Zenker M, Heldt JM, Steinbach J, Cordes N, Baumann M, Kotzerke J, Kunz-Schughart LA (2012) Flow cytometric cell-based assay to preselect antibody constructs for radionuclide conjugation. Cytom A 81:865\u2013873. https:\/\/doi.org\/10.1002\/cyto.a.22110","journal-title":"Cytom A"},{"key":"4724_CR26","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.04.027","volume":"394","author":"K Jain","year":"2010","unstructured":"Jain K, Kesharwani P, Gupta U, Jain NK (2010) Dendrimer toxicity: let\u2019s meet the challenge. Int J Pharm 394:122\u2013142. https:\/\/doi.org\/10.1016\/j.ijpharm.2010.04.027","journal-title":"Int J Pharm"},{"key":"4724_CR27","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/ijms20092323","volume":"20","author":"J Jeon","year":"2019","unstructured":"Jeon J (2019) Review of therapeutic applications of radiolabeled functional nanomaterials. Int J Mol Sci 20:2323. https:\/\/doi.org\/10.3390\/ijms20092323","journal-title":"Int J Mol Sci"},{"key":"4724_CR28","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11033-018-4455-6","volume":"46","author":"MR Kandi","year":"2019","unstructured":"Kandi MR, Mohammadnejad J, Shafiee Ardestani M, Zabihollahi R, Soleymani S, Aghasadeghi MR, Baesi K (2019) Inherent anti-HIV activity of biocompatible anionic citrate-PEG-citrate dendrimer. Mol Biol Rep 46:143\u2013149. https:\/\/doi.org\/10.1007\/s11033-018-4455-6","journal-title":"Mol Biol Rep"},{"issue":"Database issue","key":"4724_CR29","doi-asserted-by":"publisher","first-page":"D1006","DOI":"10.1093\/nar\/gkn838","volume":"37","author":"MP Lefranc","year":"2009","unstructured":"Lefranc MP, Giudicelli V, Ginestoux C, Jabado-Michaloud J, Folch G, Bellahcene F, Wu Y, Gemrot E, Brochet X, Lane J, Regnier L, Ehrenmann F, Lefranc G, Duroux P (2009) IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res 37(Database issue):D1006\u2013D1012. https:\/\/doi.org\/10.1093\/nar\/gkn838","journal-title":"Nucleic Acids Res"},{"key":"4724_CR30","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccr.2005.03.003","volume":"7","author":"S Li","year":"2005","unstructured":"Li S, Schmitz KR, Jeffrey PD, Wiltzius JJ, Kussie P, Ferguson KM (2005) Structural basis for inhibition of the epidermal growth factor receptor by cetuximab. Cancer Cell 7:301\u2013311. https:\/\/doi.org\/10.1016\/j.ccr.2005.03.003","journal-title":"Cancer Cell"},{"key":"4724_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12907-019-0085-8","volume":"19","author":"JL Li","year":"2019","unstructured":"Li JL, Lin SH, Chen HQ, Liang LS, Mo XW, Lai H, Zhang J, Xu J, Gao BQ, Feng Y, Lin Y (2019) Clinical significance of HER2 and EGFR expression in colorectal cancer patients with ovarian metastasis. BMC Clin Pathol 19:3. https:\/\/doi.org\/10.1186\/s12907-019-0085-8","journal-title":"BMC Clin Pathol"},{"key":"4724_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.actbio.2019.01.025","volume":"86","author":"WS Liao","year":"2019","unstructured":"Liao WS, Ho Y, Lin YW, Naveen Raj E, Liu KK, Chen C, Zhou XZ, Lu KP, Chao JI (2019) Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite. Acta Biomater 86:395\u2013405. https:\/\/doi.org\/10.1016\/j.actbio.2019.01.025","journal-title":"Acta Biomater"},{"key":"4724_CR33","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1021\/acs.biomac.6b00929","volume":"17","author":"F Liko","year":"2016","unstructured":"Liko F, Hindr\u00e9 F, Fernandez-Megia E (2016) Dendrimers as innovative radiopharmaceuticals in cancer radionanotherapy. Biomacromol 17:3103\u20133114","journal-title":"Biomacromol"},{"key":"4724_CR34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1021\/mp4005047","volume":"11","author":"Z Liu","year":"2014","unstructured":"Liu Z, Ma T, Liu H, Jin Z, Sun X, Zhao H, Shi J, Jia B, Li F, Wang F (2014) 177Lu-labeled antibodies for EGFR-targeted SPECT\/CT imaging and radioimmunotherapy in a preclinical head and neck carcinoma model. Mol Pharm 11:800\u2013807. https:\/\/doi.org\/10.1021\/mp4005047","journal-title":"Mol Pharm"},{"key":"4724_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0592-z","volume":"27","author":"RM Lu","year":"2020","unstructured":"Lu RM, Hwang YC, Liu IJ, Lee CC, Tsai HZ, Li HJ, Wu HC (2020) Development of therapeutic antibodies for the treatment of diseases. J Biomed Sci 27:1. https:\/\/doi.org\/10.1186\/s12929-019-0592-z","journal-title":"J Biomed Sci"},{"key":"4724_CR36","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1573405611309010008","volume":"9","author":"ME Lyra","year":"2013","unstructured":"Lyra ME, Andreou M, Georgantzoglou A, Kordolaimi S, Lagopati N, Ploussi A, Salvara AL, Vamvakas I (2013) Radionuclides used in nuclear medicine therapy\u2014from production to dosimetry. Curr Med Imaging 9:51\u201375","journal-title":"Curr Med Imaging"},{"key":"4724_CR37","doi-asserted-by":"publisher","first-page":"5790","DOI":"10.1038\/s41598-021-84171-3","volume":"11","author":"K Makabe","year":"2021","unstructured":"Makabe K, Yokoyama T, Uehara S, Uchikubo-Kamo T, Shirouzu M, Kimura K, Tsumoto K, Asano R, Tanaka Y, Kumaga I (2021) Anti-EGFR antibody 528 binds to domain III of EGFR at a site shifted from the cetuximab epitope. Sci Rep 11:5790. https:\/\/doi.org\/10.1038\/s41598-021-84171-3","journal-title":"Sci Rep"},{"key":"4724_CR38","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.ijpharm.2007.02.037","volume":"339","author":"E Markatou","year":"2007","unstructured":"Markatou E, Gionis V, Chryssikos GD, Hatziantoniou S, Georgopoulos A, Demetzos C (2007) Molecular interactions between dimethoxycurcumin and Pamam dendrimer carriers. Int J Pharm 339:231\u2013236. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.02.037","journal-title":"Int J Pharm"},{"key":"4724_CR39","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.colsurfb.2017.07.089","volume":"159","author":"A Narmani","year":"2017","unstructured":"Narmani A, Yavari K, Mohammadnejad J (2017) Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex. Colloids Surf B Biointerfaces 159:232\u2013240. https:\/\/doi.org\/10.1016\/j.colsurfb.2017.07.089","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4724_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10544-020-00485-5","volume":"22","author":"A Narmani","year":"2020","unstructured":"Narmani A, Arani MAA, Mohammadnejad J, Vaziri AZ, Solymani S, Yavari K, Talebi F, Darzi SJ (2020) Breast tumor targeting with PAMAM-PEG-5FU-99mTc as a new therapeutic nanocomplex: in in-vitro and in-vivo studies. Biomed Microdevices 22:31. https:\/\/doi.org\/10.1007\/s10544-020-00485-5","journal-title":"Biomed Microdevices"},{"key":"4724_CR41","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1002\/jlcr.3204","volume":"57","author":"Z Novy","year":"2014","unstructured":"Novy Z, Laznickova A, Mandikova J, Barta P, Laznicek M, Trejtnar F (2014) The effect of chelator type on in vitro receptor binding and stability in 177Lu-labeled cetuximab and panitumumab. J Label Comp Radiopharm 57:448\u2013452. https:\/\/doi.org\/10.1002\/jlcr.3204","journal-title":"J Label Comp Radiopharm"},{"key":"4724_CR42","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12951-016-0197-6","volume":"14","author":"N Oddone","year":"2016","unstructured":"Oddone N, Lecot N, Fern\u00e1ndez M, Rodriguez-Haralambides A, Cabral P, Cerecetto H, Benech JC (2016) In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. J Nanobiotechnol 14:45. https:\/\/doi.org\/10.1186\/s12951-016-0197-6","journal-title":"J Nanobiotechnol"},{"key":"4724_CR43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s0092-8674(02)00963-7","volume":"110","author":"H Ogiso","year":"2002","unstructured":"Ogiso H, Ishitani R, Nureki O, Fukai S, Yamanaka M, Kim JH, Saito K, Sakamoto A, Inoue M, Shirouzu M, Yokoyama S (2002) Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains. Cell 110:775\u2013787. https:\/\/doi.org\/10.1016\/s0092-8674(02)00963-7","journal-title":"Cell"},{"key":"4724_CR44","doi-asserted-by":"publisher","first-page":"941","DOI":"10.4155\/tde.12.76","volume":"3","author":"RM Pearson","year":"2012","unstructured":"Pearson RM, Sunoqrot S, Hsu HJ, Bae JW, Hong S (2012) Dendritic nanoparticles: the next generation of nanocarriers? Ther Deliv 3:941\u2013959. https:\/\/doi.org\/10.4155\/tde.12.76","journal-title":"Ther Deliv"},{"key":"4724_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1080\/09540105.2017.1365822","volume":"29","author":"X Peng","year":"2018","unstructured":"Peng X, Kang L, Pang F, Li H, Luo R, Luo X, Sun F (2018) A signal-enhanced lateral flow strip biosensor for ultrasensitive and on-site detection of bisphenol A. Food Agric Immunol 29:216\u2013227","journal-title":"Food Agric Immunol"},{"key":"4724_CR46","doi-asserted-by":"publisher","first-page":"118775","DOI":"10.1016\/j.ijpharm.2019.118775","volume":"572","author":"R Sabra","year":"2019","unstructured":"Sabra R, Billa N, Roberts CJ (2019) Cetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer. Int J Pharm 572:118775. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.118775","journal-title":"Int J Pharm"},{"key":"4724_CR47","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.3748\/wjg.v16.i10.1177","volume":"16","author":"Z Saridaki","year":"2010","unstructured":"Saridaki Z, Georgoulias V, Souglakos J (2010) Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer. World J Gastroenterol 16:1177\u20131187. https:\/\/doi.org\/10.3748\/wjg.v16.i10.1177","journal-title":"World J Gastroenterol"},{"key":"4724_CR48","unstructured":"Saxena G (2012) Synthesis and characterization of doxorubicin carrying cetuximab-pamam dendrimer bioconjugates"},{"key":"4724_CR49","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1515\/ract-2015-2499","volume":"104","author":"S Shanehsazzadeh","year":"2016","unstructured":"Shanehsazzadeh S, Gr\u00fcttner C, Yousefnia A, Lahooti A, Gholami A, Nosrati S, Zolghadri S, Anijdan HM, Lotfabadi A, Shiri Varnamkhasti B, Daha FJ, Jalilian A (2016) Development of 177Lu-DTPA-SPIO conjugates for potential use as a dual contrast SPECT\/MRI imaging agent. Radiochim Acta 104:337\u2013344","journal-title":"Radiochim Acta"},{"key":"4724_CR50","doi-asserted-by":"publisher","first-page":"e66302","DOI":"10.1371\/journal.pone.0066302","volume":"8","author":"K Shigeta","year":"2013","unstructured":"Shigeta K, Hayashida T, Hoshino Y, Okabayashi K, Endo T, Ishii Y, Hasegawa H, Kitagawa Y (2013) Expression of epidermal growth factor receptor detected by cetuximab indicates its efficacy to inhibit in vitro and in vivo proliferation of colorectal cancer cells. PLoS\u00a0One 8:e66302. https:\/\/doi.org\/10.1371\/journal.pone.0066302","journal-title":"PLoS\u00a0One"},{"key":"4724_CR51","doi-asserted-by":"publisher","first-page":"e0163366","DOI":"10.1371\/journal.pone.0163366","volume":"11","author":"EA Sickmier","year":"2016","unstructured":"Sickmier EA, Kurzeja RJ, Michelsen K, Vazir M, Yang E, Tasker AS (2016) The Panitumumab EGFR complex reveals a binding mechanism that overcomes cetuximab induced resistance. PLoS\u00a0One 11:e0163366. https:\/\/doi.org\/10.1371\/journal.pone.0163366","journal-title":"PLoS\u00a0One"},{"issue":"1","key":"4724_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2018","unstructured":"Sigismund S, Avanzato D, Lanzetti L (2018) Emerging functions of the EGFR in cancer. Mol Oncol 12(1):3\u201320. https:\/\/doi.org\/10.1002\/1878-0261.12155","journal-title":"Mol Oncol"},{"key":"4724_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1590\/S1516-89132002000500007","volume":"45","author":"SC Srivastava","year":"2002","unstructured":"Srivastava SC (2002) Bone-seeking therapeutic radiopharmaceuticals. Braz Arch Biol Technol 45:45\u201355","journal-title":"Braz Arch Biol Technol"},{"key":"4724_CR54","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4724_CR55","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40336-018-0283-x","volume":"6","author":"M Varani","year":"2018","unstructured":"Varani M, Galli F, Auletta S, Signore A (2018) Radiolabelled nanoparticles for cancer diagnosis. Clin Transl Imaging 6:271\u2013292. https:\/\/doi.org\/10.1007\/s40336-018-0283-x","journal-title":"Clin Transl Imaging"},{"key":"4724_CR56","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1007\/s00018-016-2210-5","volume":"73","author":"M Vilalta","year":"2016","unstructured":"Vilalta M, Rafat M, Graves EE (2016) Effects of radiation on metastasis and tumor cell migration. Cell Mol Life Sci 73:2999\u20133007. https:\/\/doi.org\/10.1007\/s00018-016-2210-5","journal-title":"Cell Mol Life Sci"},{"key":"4724_CR57","doi-asserted-by":"publisher","first-page":"11346","DOI":"10.1021\/acs.est.7b03364","volume":"51","author":"L Wang","year":"2017","unstructured":"Wang L, Qi T, Hu M, Zhang S, Xu P, Qi D, Wu S, Xiao H (2017) Inhibiting mercury re-emission and enhancing magnesia recovery by cobalt-loaded carbon nanotubes in a novel magnesia desulfurization process. Environ Sci Technol 51:11346\u201311353","journal-title":"Environ Sci Technol"},{"key":"4724_CR58","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1021\/la9620263","volume":"13","author":"DM Watkins","year":"1997","unstructured":"Watkins DM, Sayed-Sweet Y, Klimash JW, Turro NJ, Tomalia DA (1997) Dendrimers with hydrophobic cores and the formation of supramolecular dendrimer-surfactant assemblies. Langmuir 13:3136\u20133141","journal-title":"Langmuir"},{"key":"4724_CR59","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1158\/1078-0432.CCR-16-2738","volume":"23","author":"JM Xu","year":"2017","unstructured":"Xu JM, Wang Y, Wang YL, Wang Y, Liu T, Ni M, Li MS, Lin L, Ge FJ, Gong C, Gu JY, Jia R, Wang HF, Chen YL, Liu RR, Zhao CH, Tan ZL, Jin Y, Zhu YP, Ogino S, Qian ZR (2017) PIK3CA Mutations contribute to acquired cetuximab resistance in patients with metastatic colorectal cancer. Clin Cancer Res 23:4602\u20134616. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-2738","journal-title":"Clin Cancer Res"},{"key":"4724_CR60","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/s0959-8049(01)00230-1","volume":"37","author":"Y Yarden","year":"2001","unstructured":"Yarden Y (2001) The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer 37:S3-8. https:\/\/doi.org\/10.1016\/s0959-8049(01)00230-1","journal-title":"Eur J Cancer"},{"key":"4724_CR61","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1172\/JCI32278","volume":"117","author":"H Zhang","year":"2007","unstructured":"Zhang H, Berezov A, Wang Q, Zhang G, Drebin J, Murali R, Greene MI (2007) ErbB receptors: from oncogenes to targeted cancer therapies. J Clin Investig 117:2051\u20132058. https:\/\/doi.org\/10.1172\/JCI32278","journal-title":"J Clin Investig"},{"key":"4724_CR62","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ajps.2013.09.001","volume":"8","author":"X Zheng","year":"2013","unstructured":"Zheng X, Wang T, Jiang H, Li Y, Jiang T, Zhang J, Wang S (2013) Incorporation of Carvedilol into PAMAM-functionalized MWNTs as a sustained drug delivery system for enhanced dissolution and drug-loading capacity. Asian J Pharm Sci 8:278\u2013286","journal-title":"Asian J Pharm Sci"},{"key":"4724_CR63","doi-asserted-by":"publisher","first-page":"1602309","DOI":"10.1002\/smll.201602309","volume":"13","author":"CN Zhu","year":"2017","unstructured":"Zhu CN, Chen G, Tian ZQ, Wang W, Zhong W, Li Z, Zhang ZL, Pang D (2017) Near-infrared fluorescent Ag2Se-cetuximab nanoprobes for targeted imaging and therapy of cancer. Small 13:1602309. https:\/\/doi.org\/10.1002\/smll.201602309","journal-title":"Small"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04724-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04724-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04724-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T17:47:49Z","timestamp":1690480069000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04724-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,8]]},"references-count":63,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["4724"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04724-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,8]]},"assertion":[{"value":"28 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The approval of the\u00a0NSTRI Ethical Committee\u00a0was obtained for conducting this research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors affirm that all the participants provided informed consent for publication of the images in Figs. 1, 2, 3, 4, 5, 6, 7 and 8.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}